BamSEC and AlphaSense Join Forces
Learn More

Ocugen, Inc.

NASDAQ: OCGN    
Share price (12/20/24): $0.77    
Market cap (12/20/24): $226 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.2
from 10-Q 2 pages Certificate of Amendment to Sixth Amended and Restated Certificate of Incorporation of Ocugen, Inc
12/34/56
EX-3.1
from 8-A12G 5 pages Ocugen, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 5 pages Ocugen, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 2 pages Amendment to the Second Amended and Restated Bylaws of Ocugen, Inc
12/34/56
EX-3.1
from 10-Q 14 pages Second Amended and Restated Bylaws of Ocugen, Inc. a Delaware Corporation Effective: August 18, 2023
12/34/56
EX-3.1
from 10-Q 1 page Certificate of Amendment of Sixth Amended and Restated Certificate of Incorporation of Ocugen, Inc
12/34/56
EX-3.5
from 10-K 11 pages Terms of Preferred Stock
12/34/56
EX-3.1
from 8-K 11 pages Terms of Preferred Stock
12/34/56
EX-3.3
from 8-K 17 pages Amended and Restated Bylaws of Ocugen, Inc. a Delaware Corporation Effective: December 8, 2014
12/34/56
EX-3.2
from 8-K 3 pages Histogenics Corporation (The “Corporation”), a Corporation Organized and Existing Under and by Virtue of the Provisions of the General Corporation Law of the State of Delaware (The “General Corporation Law”): Does Hereby Certify: First: That the Name of This Corporation Is Histogenics Corporation. the Original Certificate of Incorporation of This Corporation Was Originally Filed With the Office of the Secretary of State of the State of Delaware on July 14, 2006 Under the Name Histogenics Corporation
12/34/56
EX-3.1
from 8-K 8 pages Histogenics Corporation (The “Corporation”), a Corporation Organized and Existing Under and by Virtue of the Provisions of the General Corporation Law of the State of Delaware (The “General Corporation Law”): Does Hereby Certify: First: That the Name of This Corporation Is Histogenics Corporation. the Original Certificate of Incorporation of This Corporation Was Originally Filed With the Office of the Secretary of State of the State of Delaware on July 14, 2006 Under the Name Histogenics Corporation
12/34/56
EX-3.3
from 8-K 21 pages Histogenics Corporation Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law 1 Terms of Preferred Stock
12/34/56
EX-3
from SC 13D 1 page Joint Filing Agreement
12/34/56
EX-3.1
from 8-K 6 pages Sixth Amended and Restated Certificate of Incorporation of Histogenics Corporation
12/34/56
EX-3.3
from S-1/A 6 pages Sixth Amended and Restated Certificate of Incorporation of Histogenics Corporation
12/34/56
EX-3.4
from S-1 18 pages Amended and Restated Bylaws of Histogenics Corporation a Delaware Corporation Effective: , 2014
12/34/56
EX-3.3
from S-1 6 pages Sixth Amended and Restated Certificate of Incorporation of Histogenics Corporation
12/34/56
EX-3.2
from S-1 23 pages Bylaws of Histogenics Corporation a Delaware Corporation
12/34/56
EX-3.1
from S-1 26 pages Fifth Amended and Restated Certificate of Incorporation of Histogenics Corporation
12/34/56
EX-3
from DRS/A 18 pages Amended and Restated Bylaws of Histogenics Corporation a Delaware Corporation Effective: , 2014
12/34/56